Labour market · 17/11/20261 min read
Gene2Cure Foundation and Viralgen collaborate to advance a portfolio of gene therapy programs for rare and ultra-rare genetic conditions
Summary
Collaboration brings together Gene2Cure's portfolio development capabilities and Viralgen's proprietary Aava™ platform to support the efficient progression of programs for rare and ultra-rare genetic conditions toward the clinic. DONOSTIA / SAN SEBASTIÁN, Spain, Nov. 17, 2026 /PRNewswire/...